Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status
Abstract Body mass index (BMI) is well known to be associated with poor prognosis in several cancers. The relationship between BMI and the long-term outcomes of patients with intrahepatic cholangiocarcinoma (ICC) is incompletely understood. This study investigated the relationships of BMI with clini...
Main Authors: | Kyohei Yugawa, Shinji Itoh, Norifumi Iseda, Takeshi Kurihara, Yoshiyuki Kitamura, Takeo Toshima, Noboru Harada, Kenichi Kohashi, Shingo Baba, Kousei Ishigami, Yoshinao Oda, Tomoharu Yoshizumi, Masaki Mori |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-85186-6 |
Similar Items
-
Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation
by: Shinji Itoh, et al.
Published: (2021-07-01) -
Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
by: Kyohei Yugawa, et al.
Published: (2018-11-01) -
CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
by: Kyohei Yugawa, et al.
Published: (2021-02-01) -
Impact of JMJD6 on intrahepatic cholangiocarcinoma
by: Fukuhara, T., et al.
Published: (2022) -
ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
by: Norifumi Iseda, et al.
Published: (2021-04-01)